Moleculin CEO, Walter Klemp, Highlights Positive Preliminary MIRACLE Trial Results in Virtual Investor "What This Means" Segment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/24/2026

1. INTC
2. DECK
3. INFY
4. AMD
5. UNP
6. RNG
7. URI
8. DGX
9. ACI
10. EW

Go back to Moleculin CEO, Walter Klemp, Highlights Positive Preliminary MIRACLE Trial Results in Virtual Investor "What This Means" Segment
METABASIS THERAPEUT (NASDAQ: MBRX) Delayed: 2.08 --0 (-0%)
Previous Close $2.08    52 Week High $9.58 
Open $2.08    52 Week Low $2.34 
Day High $2.08    P/E N/A 
Day Low $2.08    EPS $-0.34 
Volume 305